101 related articles for article (PubMed ID: 26525105)
1. The increase of oncogenic miRNA expression in tongue carcinogenesis of a mouse model.
Kao YY; Tu HF; Kao SY; Chang KW; Lin SC
Oral Oncol; 2015 Dec; 51(12):1103-12. PubMed ID: 26525105
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
[TBL] [Abstract][Full Text] [Related]
3. Cold Atmospheric Plasma Jet Irradiation Decreases the Survival and the Expression of Oncogenic miRNAs of Oral Carcinoma Cells.
Cheng YC; Chang KW; Pan JH; Chen CY; Chou CH; Tu HF; Li WC; Lin SC
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068984
[TBL] [Abstract][Full Text] [Related]
4. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.
Wong TS; Liu XB; Wong BY; Ng RW; Yuen AP; Wei WI
Clin Cancer Res; 2008 May; 14(9):2588-92. PubMed ID: 18451220
[TBL] [Abstract][Full Text] [Related]
5. Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis.
Josse C; Bouznad N; Geurts P; Irrthum A; Huynh-Thu VA; Servais L; Hego A; Delvenne P; Bours V; Oury C
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G229-43. PubMed ID: 24464560
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder.
Hung KF; Liu CJ; Chiu PC; Lin JS; Chang KW; Shih WY; Kao SY; Tu HF
Oral Oncol; 2016 Feb; 53():42-7. PubMed ID: 26675284
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer.
Zhong M; Ma X; Sun C; Chen L
Chem Biol Interact; 2010 Mar; 184(3):431-8. PubMed ID: 20097187
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.
Lu YC; Chen YJ; Wang HM; Tsai CY; Chen WH; Huang YC; Fan KH; Tsai CN; Huang SF; Kang CJ; Chang JT; Cheng AJ
Cancer Prev Res (Phila); 2012 Apr; 5(4):665-74. PubMed ID: 22318752
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
Li L; Ma HQ
Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
12. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
Liu CJ; Lin SC; Yang CC; Cheng HW; Chang KW
Head Neck; 2012 Feb; 34(2):219-24. PubMed ID: 22083872
[TBL] [Abstract][Full Text] [Related]
13. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer.
Liu CJ; Kao SY; Tu HF; Tsai MM; Chang KW; Lin SC
Oral Dis; 2010 May; 16(4):360-4. PubMed ID: 20233326
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of 4NQO-Induced Mouse Tongue Carcinogenesis by AKT Inhibitor through the MMP-9/RhoC Signaling Pathway and Autophagy.
Yin P; Chen J; Wu Y; Gao F; Wen J; Zhang W; Su Y; Zhang X
Anal Cell Pathol (Amst); 2022; 2022():3770715. PubMed ID: 36247874
[TBL] [Abstract][Full Text] [Related]
15. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
16. K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression.
Tseng SH; Yang CC; Yu EH; Chang C; Lee YS; Liu CJ; Chang KW; Lin SC
Int J Cancer; 2015 Mar; 136(6):1263-75. PubMed ID: 25082302
[TBL] [Abstract][Full Text] [Related]
17. The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.
Lin SC; Liu CJ; Ji SH; Hung WW; Liu YC; Chang SR; Tu HF; Chang KW
Clin Oral Investig; 2022 Feb; 26(2):1343-1351. PubMed ID: 34342761
[TBL] [Abstract][Full Text] [Related]
18. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
Chi H
Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
[TBL] [Abstract][Full Text] [Related]
19. Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma.
Shi Z; Johnson JJ; Jiang R; Liu Y; Stack MS
Arch Oral Biol; 2015 Sep; 60(9):1416-27. PubMed ID: 26159827
[TBL] [Abstract][Full Text] [Related]
20. The receptor for advanced glycation end products is dispensable in a mouse model of oral and esophageal carcinogenesis.
Mark R; Bermejo JL; Bierhaus A; Plinkert PK; Angel P; Hess J
Histol Histopathol; 2013 Dec; 28(12):1585-94. PubMed ID: 23712426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
